Orocidin and Bio-Convert expects to begin pilot efficacy studies in 2025
December 17, 2024 15:00 ET
|
Nordicus Partners Corporation
BEVERLY HILLS, California, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB:NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic...
Orocidin – New Insights Into The Treatment Of Periodontitis
June 11, 2024 09:15 ET
|
Nordicus Partners Corporation
Beverly Hills, California., June 11, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing...